scispace - formally typeset
M

Michele Till

Researcher at Northwestern University

Publications -  14
Citations -  844

Michele Till is an academic researcher from Northwestern University. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & In situ hybridization. The author has an hindex of 11, co-authored 14 publications receiving 834 citations. Previous affiliations of Michele Till include Maimonides Medical Center.

Papers
More filters
Journal ArticleDOI

Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry

TL;DR: It is now possible to detect single-copy DNA or low-abundance messenger RNA rapidly and reproducibly in a minor subpopulation of cells in suspension at single-cell resolution and to sort those cells for further characterization.
Journal ArticleDOI

Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution

TL;DR: The alternative states of HIV-gene expression and high local concentration of latently infected lymphocytes and monocytes revealed by these studies conceptually supports models of lentiviral pathogenesis that attribute persistence to the reservoir of latent infected cells and disease to the consequences of viral-Gene expression in this population.
Journal ArticleDOI

Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine?

TL;DR: This data indicates that early therapy with zidovudine is beneficial in slowing disease progression in persons infected with the human immunodeficiency virus type 1 (HIV-1) when CD4 cell counts are low.
Journal ArticleDOI

High-Level Gentamicin Resistance in Enterococcus faecalis Bacteremia

TL;DR: It is suggested that high-level resistance adversely affects survival with a pure E. faecalis bacteremia or low-risk bactEREmic source, and response to antibiotic therapy may be diminished by high- level resistance.
Journal ArticleDOI

Transient Viremia in HIV-Infected Patients and Use of Plasma Preparation Tubes

TL;DR: Using plasma preparation tubes for the collection and storage of plasma resulted in factitious, low-level human immunodeficiency virus type 1 (HIV-1) viremia among patients receiving highly active antiretroviral therapy who incurred unnecessary additional clinic visits, laboratory testing, and medication changes.